darifenacin 7.5 MG (as darifenacin HBr 8.923 MG) 24 HR Extended Release Oral Tablet

RxCUI
485423
RxNorm name
darifenacin 7.5 MG (as darifenacin HBr 8.923 MG) 24 HR Extended Release Oral Tablet
Display name
darifenacin 7.5 MG (as darifenacin HBr 8.923 MG) 24 HR Extended Release Oral Tablet
Full name
darifenacin 7.5 MG (as darifenacin HBr 8.923 MG) 24 HR Extended Release Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:02

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 9 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
DarifenacinDARIFENACINTorrent Pharmaceuticals Limitede84f1ae3-b9a2-4a15-a299-c75373891cc12026-02-10Warnings, Adverse reactionsExact identifier
rxcui: 485423
DarifenacinDARIFENACINBryant Ranch Prepack697eba55-9e1f-4036-baed-5644c810f1662025-11-17Warnings, Adverse reactionsExact identifier
rxcui: 485423
DarifenacinDARIFENACIN HYDROBROMIDECipla USA Inc.6e8470d1-c3e6-4644-b70a-aa47ddf796762025-10-27Warnings, Adverse reactionsExact identifier
rxcui: 485423
DarifenacinDARIFENACINAurobindo Pharma Limited28ed5b58-46dd-4140-a877-4b422f780a942024-04-19Warnings, Adverse reactionsExact identifier
rxcui: 485423
DarifenacinDARIFENACINRising Pharma Holdings, Inc.e2aa9544-0136-463d-a73b-1a299534446a2024-04-19Warnings, Adverse reactionsExact identifier
rxcui: 485423
DARIFENACINDARIFENACINAlembic Pharmaceuticals Limitedda7c2732-232c-4e71-92d9-577ef8617f562023-01-30Warnings, Adverse reactionsExact identifier
rxcui: 485423
DarifenacinDARIFENACINMacleods Pharmaceuticals Limited7ae60119-e22c-4806-a5d8-db7c9e8984a22023-01-25Warnings, Adverse reactionsExact identifier
rxcui: 485423
DarifenacinDARIFENACIN HYDROBROMIDEPOLYGEN PHARMACEUTICALS INC.62a72d3e-3c33-4f2d-b3d0-2e014f704c632022-12-01Warnings, Adverse reactionsExact identifier
rxcui: 485423
DARIFENACINDARIFENACINAlembic Pharmaceuticals Inc.9f6952c8-e547-4f3e-a978-a88d6ea9dc102021-12-13Warnings, Adverse reactionsExact identifier
rxcui: 485423

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 12 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
697eba55-9e1f-4036-baed-5644c810f166darifenacin 7.5 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR darifenacin 7.5 MG Extended Release Oral Tablet [SCD] · darifenacin 7.5 MG (as darifenacin HBr 8.923 MG) 24 HR Extended Release Oral Tablet [SY]3100These highlights do not include all the information needed to use DARIFENACIN EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for DARIFENACIN EXTENDED-RELEASE TABLETS. DARIFENACIN extended-release tablets, for oral use Initial U.S. Approval:200420251117
e84f1ae3-b9a2-4a15-a299-c75373891cc1darifenacin 7.5 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR darifenacin 7.5 MG Extended Release Oral Tablet [SCD] · darifenacin 7.5 MG (as darifenacin HBr 8.923 MG) 24 HR Extended Release Oral Tablet [SY]310These highlights do not include all the information needed to use DARIFENACIN EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for DARIFENACIN EXTENDED-RELEASE TABLETS. DARIFENACIN extended-release tablets, for oral use Initial U.S. Approval:200420260210
6e8470d1-c3e6-4644-b70a-aa47ddf79676darifenacin 7.5 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR darifenacin 7.5 MG Extended Release Oral Tablet [SCD] · darifenacin 7.5 MG (as darifenacin HBr 8.923 MG) 24 HR Extended Release Oral Tablet [SY]39These highlights do not include all the information needed to use DARIFENACIN EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for DARIFENACIN EXTENDED-RELEASE TABLETS. DARIFENACIN extended-release tablets, for oral use Initial U.S. Approval: 200420251027
9f6952c8-e547-4f3e-a978-a88d6ea9dc10darifenacin 7.5 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR darifenacin 7.5 MG Extended Release Oral Tablet [SCD] · darifenacin 7.5 MG (as darifenacin HBr 8.923 MG) 24 HR Extended Release Oral Tablet [SY]38These highlights do not include all the information needed to use DARIFENACIN EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for DARIFENACIN EXTENDED-RELEASE TABLETS. DARIFENACIN extended-release tablets, for oral use Initial U.S. Approval: 200420211213
28ed5b58-46dd-4140-a877-4b422f780a94darifenacin 7.5 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR darifenacin 7.5 MG Extended Release Oral Tablet [SCD] · darifenacin 7.5 MG (as darifenacin HBr 8.923 MG) 24 HR Extended Release Oral Tablet [SY]35These highlights do not include all the information needed to use DARIFENACIN EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for DARIFENACIN EXTENDED-RELEASE TABLETS. DARIFENACIN extended-release tablets, for oral use Initial U.S. Approval: 200420240419
d09e16f4-42a9-402f-a37b-2eca55ceafbfdarifenacin 7.5 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR darifenacin 7.5 MG Extended Release Oral Tablet [SCD] · darifenacin 7.5 MG (as darifenacin HBr 8.923 MG) 24 HR Extended Release Oral Tablet [SY]35These highlights do not include all the information needed to use DARIFENACIN extended-release tablets safely and effectively. See full prescribing information for DARIFENACIN extended-release tablets. DARIFENACIN extended-release tablets Initial U.S. Approval: 200420200409
7ae60119-e22c-4806-a5d8-db7c9e8984a2darifenacin 7.5 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR darifenacin 7.5 MG Extended Release Oral Tablet [SCD] · darifenacin 7.5 MG (as darifenacin HBr 8.923 MG) 24 HR Extended Release Oral Tablet [SY]34These highlights do not include all the information needed to use DARIFENACIN EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for DARIFENACIN EXTENDED-RELEASE TABLETS. DARIFENACIN extended-release tablets, for oral use Initial U.S. Approval: 200420230125
da7c2732-232c-4e71-92d9-577ef8617f56darifenacin 7.5 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR darifenacin 7.5 MG Extended Release Oral Tablet [SCD] · darifenacin 7.5 MG (as darifenacin HBr 8.923 MG) 24 HR Extended Release Oral Tablet [SY]33These highlights do not include all the information needed to use DARIFENACIN EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for DARIFENACIN EXTENDED-RELEASE TABLETS. DARIFENACIN extended-release tablets, for oral use Initial U.S. Approval: 200420230130
62a72d3e-3c33-4f2d-b3d0-2e014f704c63darifenacin 7.5 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR darifenacin 7.5 MG Extended Release Oral Tablet [SCD] · darifenacin 7.5 MG (as darifenacin HBr 8.923 MG) 24 HR Extended Release Oral Tablet [SY]33These highlights do not include all the information needed to use DARIFENACIN EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for DARIFENACIN EXTENDED-RELEASE TABLETS. DARIFENACIN extended-release tablets, for oral use Initial U.S. Approval: 200420221201
e2aa9544-0136-463d-a73b-1a299534446adarifenacin 7.5 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR darifenacin 7.5 MG Extended Release Oral Tablet [SCD] · darifenacin 7.5 MG (as darifenacin HBr 8.923 MG) 24 HR Extended Release Oral Tablet [SY]32These highlights do not include all the information needed to use DARIFENACIN EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for DARIFENACIN EXTENDED-RELEASE TABLETS. DARIFENACIN extended-release tablets, for oral use Initial U.S. Approval: 200420240419
7e9f2cec-8c9f-7668-dfb4-6ab57c9d3e8adarifenacin 7.5 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR darifenacin 7.5 MG Extended Release Oral Tablet [SCD] · darifenacin 7.5 MG (as darifenacin HBr 8.923 MG) 24 HR Extended Release Oral Tablet [SY]31These highlights do not include all the information needed to use DARIFENACIN EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for DARIFENACIN EXTENDED-RELEASE TABLETS. DARIFENACIN extended-release tablets, for oral use Initial U.S. Approval: 200420210430
a293cece-e97a-4e67-be72-b187568e3b11darifenacin 7.5 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR darifenacin 7.5 MG Extended Release Oral Tablet [SCD] · darifenacin 7.5 MG (as darifenacin HBr 8.923 MG) 24 HR Extended Release Oral Tablet [SY]31ENABLEX ® (darifenacin) Extended -release tablets Rx only Prescribing Information20100101